Activation of pyruvate dehydrogenase by dichloroacetate has the potential to induce epigenetic remodeling in the heart

Journal of Molecular and Cellular Cardiology
Tomohiro MatsuhashiMotoaki Sano

Abstract

Dichloroacetate (DCA) promotes pyruvate entry into the Krebs cycle by inhibiting pyruvate dehydrogenase (PDH) kinase and thereby maintaining PDH in the active dephosphorylated state. DCA has recently gained attention as a potential metabolic-targeting therapy for heart failure but the molecular basis of the therapeutic effect of DCA in the heart remains a mystery. Once-daily oral administration of DCA alleviates pressure overload-induced left ventricular remodeling. We examined changes in the metabolic fate of pyruvate carbon (derived from glucose) entering the Krebs cycle by metabolic interventions of DCA. (13)C6-glucose pathway tracing analysis revealed that instead of being completely oxidized in the mitochondria for ATP production, DCA-mediated PDH dephosphorylation results in an increased acetyl-CoA pool both in control and pressure-overloaded hearts. DCA induces hyperacetylation of histone H3K9 and H4 in a dose-dependent manner in parallel to the dephosphorylation of PDH in cultured cardiomyocytes. DCA administration increases histone H3K9 acetylation in in vivo mouse heart. Interestingly, DCA-dependent histone acetylation was associated with an up-regulation of 2.3% of genes (545 out of 23,474 examined). Gene ontology an...Continue Reading

References

Sep 25, 1991·Proceedings of the National Academy of Sciences of the United States of America·H A RockmanK R Chien
Jan 1, 1988·The American Journal of Cardiology·T J WargovichC J Pepine
Nov 1, 1985·The Journal of Clinical Investigation·J A WisneskiJ C Craig
Dec 16, 1998·Clinical Cardiology·J F LewisP Stacpoole
Oct 12, 2000·Journal of the American College of Cardiology·R B WamboltM F Allard
Mar 30, 2002·Cardiovascular Research·Carmen P LydellMichael F Allard
May 23, 2003·The Journal of Biological Chemistry·Christopher L AntosEric N Olson
Jan 6, 2007·Genome Biology·Pedro Carmona-SaezAlberto Pascual-Montano
Apr 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Sudeshna FischMukesh K Jain
Feb 12, 2008·American Journal of Respiratory and Critical Care Medicine·Lori D CalvertMichael C Steiner
May 23, 2009·Science·Jeffrey C Rathmell, Christopher B Newgard
May 23, 2009·Science·Kathryn E WellenCraig B Thompson
May 26, 2009·Molecular and Cellular Endocrinology·Stephen A MyersGeorge E O Muscat
May 26, 2009·Nucleic Acids Research·Ruben Nogales-CadenasAlberto Pascual-Montano
Sep 5, 2009·Journal of Molecular and Cellular Cardiology·Hae Jin Kee, Hyun Kook
Dec 2, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Lin PiaoStephen L Archer
Feb 24, 2010·Circulation. Heart Failure·Takao KatoTetsuo Shioi
May 4, 2010·Journal of Molecular and Cellular Cardiology·Xudong LiaoMukesh K Jain
May 25, 2011·Molecular and Cellular Biology·Shoumei Bai, Tom K Kerppola
Jan 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Takayuki MorikawaMakoto Suematsu
Mar 20, 2012·Cell·Ralph J DeBerardinis, Craig B Thompson
Jul 10, 2012·Cell Metabolism·Chao Lu, Craig B Thompson
Mar 19, 2013·Trends in Cardiovascular Medicine·Min Xie, Joseph A Hill

❮ Previous
Next ❯

Citations

Mar 16, 2016·Metabolism: Clinical and Experimental·Dong-Xia ZhangYue-Sheng Huang
May 6, 2015·Journal of Molecular and Cellular Cardiology·Giovanni Davogustto, Heinrich Taegtmeyer
Jun 21, 2016·International Journal of Cardiology·M Marcinkiewicz-SiemionK A Kaminski
Jun 23, 2018·Circulation Research·Andrew A Gibb, Bradford G Hill
Mar 30, 2016·Current Opinion in Cardiology·Soo Young KimJoseph A Hill
Jun 20, 2018·Nature Reviews. Cardiology·Edoardo Bertero, Christoph Maack
Jan 2, 2021·World Journal of Diabetes·Souad NasserLuciano Pirola
Jun 3, 2021·Life·Giampaolo MorcianoPaolo Pinton
Jun 1, 2021·Neuroscience Research·Azumi NoguchiTakumi Takizawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Related Papers

Frontiers in Oncology
Gopinath Sutendra, Evangelos D Michelakis
American Journal of Physiology. Heart and Circulatory Physiology
Steven LloydJohn C Chatham
© 2022 Meta ULC. All rights reserved